NCT01033487
- Conditions
- COPD, Chronic Disease, Chronic Obstructive Airway Disease, +7 more
- Locations
-
- Pfizer Investigational Site Berlin, Germany
Clinical trial condition
Pulmonary Disease, Chronic Obstructive
Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.
787 public trials
11 recruiting studies
Pulmonary Disease, Chronic Obstructive trial results
NCT01969721
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 1237.11.32002 Boehringer Ingelheim Investigational Site Genk, Belgium
- 1237.11.32001 Boehringer Ingelheim Investigational Site Ghent, Belgium
- 1237.11.42003 Boehringer Ingelheim Investigational Site Kyjov, Czechia
- 1237.11.42004 Boehringer Ingelheim Investigational Site Rokycany, Czechia
Completed
Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines
NCT00615992
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- Boehringer Ingelheim Investigational Site Admont, Austria
- Boehringer Ingelheim Investigational Site Afritz Am See, Austria
- Boehringer Ingelheim Investigational Site Altenmarkt, Austria
- Boehringer Ingelheim Investigational Site Altmünster, Austria
Completed
Telehealth Program in Chronic Patients
NCT02269618
- Conditions
- Cardiovascular Diseases, Chronic Disease, Disease Attributes, +8 more
- Locations
-
- FSM Respiratory Unit Lumezzane, BS, Italy
- Fondazione Salvatore Maugeri, Cardiology Unit Lumezzane, BS, Italy
- Fondazione Salvatore Maugeri, Telemedicine Service Lumezzane, BS, Italy
NCT00932646
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 1222.25.25009 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
- 1222.25.25002 Boehringer Ingelheim Investigational Site Clearwater, Florida, United States
- 1222.25.25003 Boehringer Ingelheim Investigational Site DeLand, Florida, United States
- 1222.25.25007 Boehringer Ingelheim Investigational Site Winter Park, Florida, United States
NCT00281216
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- University of Michigan at Ann Arbor Ann Arbor, Michigan, United States
Completed
Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT00281242
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- University of Michigan at Ann Arbor Ann Arbor, Michigan, United States
NCT02006732
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 1237.26.10620 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
- 1237.26.10618 Boehringer Ingelheim Investigational Site Stamford, Connecticut, United States
- 1237.26.10619 Boehringer Ingelheim Investigational Site Clearwater, Florida, United States
- 1237.26.10614 Boehringer Ingelheim Investigational Site Tampa, Florida, United States
NCT02231177
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
Not specified
Completed
Innate Immune Response in COPD
NCT02637219
- Conditions
- Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +13 more
- Locations
-
- VA Puget Sound Health Care System Seattle, Washington, United States